Accure Therapeutics is a private pharma R&D engine at clinical stage in the CNS field.
Accure Therapeutics has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in April 2025.
Accure Therapeutics's investors include Michael J. Fox Foundation, Centre for the Development of Industrial Technology (CDTI), Alta Life Sciences, Kinled Holding, Luxembourg National Research Fund.
Accure Therapeutics is headquartered in Barcelona, Spain.
Accure Therapeutics is a private pharma R&D engine at clinical stage in the CNS field.
Accure Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Accure Therapeutics — Funding & Investors." VCBacked, April 7, 2025, https://www.vcbacked.co/company/accure-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Accure Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/accure-therapeutics
{{cite web |title=Accure Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/accure-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated